The Effects of HLA-DRβ1 Specific Hyporesponsive Peptide on T Cell Activation in Rheumatoid Arthritis

周强,穆荣,何菁,吕厚山,栗占国
DOI: https://doi.org/10.3760/j:issn:1007-7480.2003.06.002
2003-01-01
Abstract:Objective To evaluate the effect of CⅡ peptides with substitution for T-cell receptor (TCR) binding residues on T cell activation in rheumatoid arthritis (RA) patients.Methods Peripheral blood mononuclear cells (PBMC) were obtained from 39 RA patients.T cells were cultured with CⅡ protein, wild-typed CⅡ263-272 peptide and modified CⅡ263-272 peptide with consecutive substitution of 268(G),269(P),270(K) by alanine (A) or glycine (G).T cell proliferation was determined by methotetrazolium (MTT) 7 days later.CⅡ antibodies in RA serum were detected by ELISA. Results T cell responses to CⅡ protein and wild-typed CⅡ263-272 peptide were observed in 22 RA patients (56%).The stimulation index (SI) of the modified CⅡ peptide was significantly lower than wild-typed peptide in 15 patients.Activation of CⅡ specific T cell was in correlation with the concentration of CⅡ antibodies.T cell activation in patients with disease duration ≤3 year was significantly higher than in those with longer duration.Conclusion CⅡ specific T cell activation played an important role in early stage of pathogenesis of RA.Non-T cell binding peptide yielded hyporesponse to CⅡ specific T cell activation,suggesting a new strategy of immunosuppresive therapy in RA.
What problem does this paper attempt to address?